Search Results 31-40 of 143 for ☆sbc주소 【위너보증.com / 가입코드 9122】 올인구조대 ☆

  2. Px Code,Supply #,Description,Unit Price 278000024,48589,CATH ABL THRMCL ST FJ,"5,504.00" 278000026,70189,CATH SWN DLYS PERIT 14FX62.5,338.5 278000027,103611 ...

  3. A Study of BHV-3241 in Subjects with Multiple System Atrophy - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Low-grade UTUC Treated with Nadofaragene Firadenovec Administered to Renal Pelvis - Mayo Clinic

    About this study. The primary purpose of this trial is to evaluate the safety \& tolerability of Nadofaragene Firadenovec in subjects with LG-UTUC.

  5. Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) - Mayo Clinic

    The purpose of this study is to determine how well SNS01-T is tolerated by relapsed or refractory multiple myeloma, B cell lymphoma or plasma cell leukemia ...

  6. ADJUSTING SIGNIFICANCE LMELS IN CENSORED DATA WHEN USING MULTIPLE TESTS SIMULTANEOUSLY by THOMAS R. FLE!YING and DAVID P. YARRIN

    I. Introduction. The last thirty years have seen a considerable increase in the amount of research literature in statistics.

  7. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

    Specifically, this study aims to demonstrate in participants with NASH and compensated cirrhosis, the effectiveness of BMS-986036 using histological and ...

  8. Academics - Find a Program at Mayo Clinic College of Medicine & Science

    Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of ...

  9. Study of TERN-601 in Adults with Overweight or Obesity - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

    This is a combination Phase I and Phase II study, with an aim to evaluate the combination of GSK525762 and fulvestrant in women with advanced or metastatic ER+ ...